bioequivalence of vit D3 cholecalciferol [Regulatives / Guidelines]

posted by khaoula – Algeria, 2020-08-18 12:41 (243 d 21:57 ago) – Posting: # 21887
Views: 758

Dear all,
I have a question about a new formulation of vit D cholecalciferol capsule 50 000 UI : is it necessary to conduct a bioequivalence study to compare this new formulation with the reference drug vitamin D3 50 000 IU oral solution in ampoule ?
knowing that the producer of this generic formulation said that the clinical and non clinical studies can be waived for medicinal product with well established medicinal use according to articlr 10A in the DIRECTIVE 2001/ 83/EC of THE EUROPEAN PARLIAMENT
we don't have guideline in Algeria , but we follow FDA and EMA guideline, or I didnt find an answer to this question
thank you

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Monday 10:38 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5